SPEEDLOCK
Device
Smith+Nephew, Inc.
Total Payments
$35,086
Transactions
55
Doctors
28
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $470.45 | 9 | 8 |
| 2023 | $31,835 | 7 | 4 |
| 2022 | $2,780 | 39 | 21 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $31,350 | 2 | 89.4% |
| Food and Beverage | $2,638 | 46 | 7.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,098 | 7 | 3.1% |
Payments by Type
Research
$31,350
2 transactions
General
$3,736
53 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Addressing anterior labrum tears associated with hip impingement with SPEEDLOCK HIP | Smith+Nephew, Inc. | $31,350 | 0 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $35,086
Product Information
- Type Device
- Total Payments $35,086
- Total Doctors 28
- Transactions 55
About SPEEDLOCK
SPEEDLOCK is a device associated with $35,086 in payments to 28 healthcare providers, recorded across 55 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2022 to 2024. In 2024, $470.45 was paid across 9 transactions to 8 doctors.
The most common payment nature for SPEEDLOCK is "Unspecified" ($31,350, 89.4% of total).
SPEEDLOCK is associated with 1 research study, including "Addressing anterior labrum tears associated with hip impingement with SPEEDLOCK HIP" ($31,350).